Sipatrigine

DB21032ExperimentalSmall molecule

Sipatrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Sipatrigine is a sodium channel blocker, signal transduction modulator. Sipatrigine has a... Sipatrigine has a monoisotopic molecular weight of 371.05 Da.

Formula / weight: C₁₅H₁₆Cl₃N₅ · 372.68 g/mol (avg)
Code names: 619-C-89

Resolves to

Compound

UNIIOON9AVW1T3CAS130800-90-7ChEMBLCHEMBL28854ChEBI34977KEGGC13852

Structure

InChIKeyPDOCBJADCWMDGL-UHFFFAOYSA-NSMILESCN1CCN(CC1)C1=NC(N)=C(C=N1)C1=C(Cl)C(Cl)=CC(Cl)=C1

Targets

Q01668CACNA1DQ9NY46SCN3AP35499SCN4AQ14524SCN5AQ15858SCN9AQ9Y5Y9SCN10A

What you can answer from here — as of September 19, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Sipatrigine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account